NAD
This article was originally published in The Tan Sheet
Executive Summary
Case against Global Vision 2021 will move to FTC after advertising statements for firm's Avacor Hair Growth System remain unsubstantiated following 15-day warning letter, CBBB division says. Print ads, online promotional materials at issue claim Avacor "stops DHT from attacking hair follicles and is guaranteed to start regrowing hair in balding areas," and "in five years of clinical testing, Avacor has shown a 90% success rate in both men and women." NAD referred case to FTC after Global Vision failed to provide requested clinical studies